SLC17A6 and Parkinson disease: These findings lead us to hypothesize that the activation of PPN-vGluT2 neurons may mirror the pathophysiological state of the PPN in PD patients, positioning it as a viable target for DBS to alleviate FOG by reducing the hyperactivity of excitatory PPN neurons.